Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
VSTM
#2683
Verastem, Inc.
5.7
2
+1.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.42%
Variazione Mensile
-11.86%
Variazione di 6 mesi
-38.49%
Variazione Annuale
+6.32%
Chiusura Precedente
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Mercati
Mercato Azionario Statunitense
Salute
VSTM
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Notizie
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley riconferma il rating Buy per le azioni Verastem, mantiene target a $16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem riporta 17,5 milioni di dollari di ricavi nel Q4 per trattamento oncologico
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Il titolo di Revolution Medicines balza oltre il 20% su possibile acquisizione AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Azioni Verastem stabili mentre Mizuho riconferma rating Outperform